After Year-Long Review, Varmus Removes “Reasonable Pricing” Clause From CRADA
In Brief: Comis Named ECOG Chairman; Long Joins Capitol Associates; Chabner Day In Shelbyville
Advisors’ Report On Intramural Program To Recommend Restructuring
Russian-American Breast Cancer Meeting Canceled
Breast Cancer Plan Issues Its First RFA, Other Initiatives To Be Announced Soon
NCI, EORTC Offer Support For Russian Cancer Researchers
Public Forum On NRSA Tuition Policies
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final









